DEFB1 and cystic fibrosis: Studies suggest a primary role for HBD1 against pulmonary pathogens relevant to bronchiectasis [44,45] and an association between HBD1 antimicrobial inactivation and recurrent airway infections in cystic fibrosis patients [51,52].